IHL 0.00% 4.1¢ incannex healthcare limited

AXIM - Patent for anti-fungals

  1. 9,792 Posts.
    lightbulb Created with Sketch. 2741
    AXIM, our American sister company, has been granted a U.S. patent to be able to develop / sell anti-fungal compositions that are cannabinoid based; all products that AXIM has the opportunity to produce under this patent will be made using CBG (cannabigerol), a strong anti-microbial agent.

    This market in itself is huge with the global anti-fungal drugs market expected to reach $12.7 billion by 2025.

    Looks like these guys have the same mindset as IHL in that their focus is in securing patents as that's where the real money is to be made.

    “We have recognized the importance of patents since our early days with our well-known patent on chewing gum as a delivery mechanism for all cannabinoids,” said John W. Huemoeller II, Chief Executive Officer of AXIM® Biotech. “We look forward to continuing to lead cannabis innovation with this patent and future patents as the industry advances both in market growth and legitimacy.”Once granted this patent, AXIM will hold eight issued patents and 11 pending patent applications.

    https://www.globenewswire.com/news-release/2019/08/08/1899275/0/en/New-U-S-Patent-Allowance-Granted-To-Axim-Biotechnologies-For-Anti-Microbial-Compositions-Comprising-Cannabinoids.html

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.